Texas Children's Hospital - Baylor College of Medicine
Welcome,         Profile    Billing    Logout  
 11 Trials 
23 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith, Andrew
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
NCT05677451: 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Recruiting
3
100
Europe, Canada, Japan, US, RoW
LOU064 (blinded), remibrutinib, placebo
Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
11/25
02/32
NCT05976243: A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Recruiting
3
348
Europe, Canada, Japan, US, RoW
Remibrutinib, Placebo
Novartis Pharmaceuticals
Chronic Inducible Urticaria
07/26
12/28
NCT05513001 / 2022-001034-11: An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

Active, not recruiting
3
698
Europe, Canada, Japan, US, RoW
LOU064 (blinded), remibrutinib, Placebo, LOU064 (open label)
Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
08/24
02/27
RAPID-I, NCT03684278: Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial

Recruiting
2
290
Europe
Infusion of 5 mg/kg Infliximab, Remicade, Infusion of 10 mg/kg Infliximab, 0.9% Sodium Chloride (Placebo)
University of Liverpool, Bangor University, Liverpool University Hospitals NHS Foundation Trust, Medical Research Council, National Institute for Health Research, United Kingdom, Merck Sharp & Dohme LLC
Acute Pancreatitis
07/26
03/27
CALM-CSU, NCT06077773: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Recruiting
2
154
Europe, Canada, US
Oral EP262, Placebo
Escient Pharmaceuticals, Inc
Chronic Spontaneous Urticaria
06/25
07/25
NCT05432388 / 2021-006950-30: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

Recruiting
2
72
Europe, US
remibrutinib, (LOU064), placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Allergy, Peanut
03/25
03/25
NCT03910413: Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices

Terminated
N/A
11
US
Duel Energy CT
University of Alabama at Birmingham
Gastroesophageal Varices
09/19
07/23
NCT01817192: Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer

Recruiting
N/A
1050
Europe, US
Adjuvant Chemotherapy, Radiographic surveillance, 14-Gene Prognostic Assay
Razor Genomics, Encore Clinical
Non-Small Cell Lung Cancer
05/27
05/27
NCT05966896: Epidural Stimulation to Restore Voluntary Movement Following Spinal Cord Injury

Not yet recruiting
N/A
2
NA
implanted epidural stimulator
University of Colorado, Denver, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Spinal Cord Injuries
01/26
08/26
TITRE, NCT05405426: Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

Recruiting
N/A
228
Canada, US, RoW
Red blood cell transfusion
Boston Children's Hospital
Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple
10/24
12/25
NCT04161417: Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer

Recruiting
N/A
2500
Europe
Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling
Judith Dixon-Hughes, Cancer Research UK, NHS Greater Glasgow and Clyde
Neoplasms Pancreatic
12/25
12/25
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50
Muscal, Eyal
BACK-OFF JSpA, NCT04891640: Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis

Recruiting
N/A
198
Canada, US
Standard TNFi Therapy, TNFi fixed longer dosing intervals, Stop TNFi treatment
Children's Hospital of Philadelphia, Patient-Centered Outcomes Research Institute
Juvenile Spondyloarthritis
07/26
07/27
NCT02418442: Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Recruiting
N/A
20000
Europe, Canada, US, RoW
Duke University, Childhood Arthritis and Rheumatology Research Alliance
Rheumatic Joint Disease
06/28
12/28
Bridges, Brian
TITRE, NCT05405426: Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

Recruiting
N/A
228
Canada, US, RoW
Red blood cell transfusion
Boston Children's Hospital
Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple
10/24
12/25
Vento, Suzanne
FIT4KID, NCT04741646: Ferric Citrate and Chronic Kidney Disease in Children

Recruiting
2
160
Canada, US
Ferric Citrate, Auryxia, Placebo
University of California, Los Angeles, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chronic Kidney Diseases
12/25
12/25
NEPTUNE, NCT01209000: Nephrotic Syndrome Study Network

Recruiting
N/A
1200
Canada, US
Kidney Biopsy
University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation
Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
06/26
06/26
kidNEY-VNS, NCT05588063: taVNS for FRNS in Children

Recruiting
N/A
30
US
Transcutaneous auricular vagus nerve stimulation, Roscoe TENS 7000, Sham device
Northwell Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
08/25
08/25
kidNEY-VNS, NCT05583942: A Pilot Trial of taVNS for SRNS in Children

Recruiting
N/A
10
US
trascutaneous auricular vagus nerve stimulation, Roscoe TENS 7000, Sham device
Northwell Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
04/25
08/25
Anders, Marc M
TITRE, NCT05405426: Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

Recruiting
N/A
228
Canada, US, RoW
Red blood cell transfusion
Boston Children's Hospital
Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple
10/24
12/25
Shah, Shweta S
NEPTUNE, NCT01209000: Nephrotic Syndrome Study Network

Recruiting
N/A
1200
Canada, US
Kidney Biopsy
University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation
Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
06/26
06/26
Deslandes, Aisha
NEPTUNE, NCT01209000: Nephrotic Syndrome Study Network

Recruiting
N/A
1200
Canada, US
Kidney Biopsy
University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation
Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
06/26
06/26

Download Options